GRPH insider filings

Graphite Bio, Inc. — 44 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-01. Screen GRPH transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for GRPH between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Graphite Bio, Inc.

FiledFormInsiderReported transactionsSource
2023-08-014Drapkin Kimberlee C — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2023-07-214Viney Joanne L. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-214Porteus Matthew — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-214Carlo Rizzuto — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-214Bassan Abraham — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-214Shah Smital — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-214Jerel Davis — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-214Hege Kristen — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-214KARSEN PERRY A — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-07-214JIMENEZ JOSEPH — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-02-234Young Alethia — Chief Financial OfficerGrant/award (A): 220,000 (derivative) @ $0EDGAR
2023-02-234Lehrer-Graiwer Joshua — PRESIDENT AND CEO, DirectorGrant/award (A): 600,000 (derivative) @ $0EDGAR
2022-06-224Viney Joanne L. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Porteus Matthew — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Carlo Rizzuto — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Bassan Abraham — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Shah Smital — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Jerel Davis — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224Hege Kristen — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224KARSEN PERRY A — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-224JIMENEZ JOSEPH — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2022-04-134Gutry Phil — CHIEF BUSINESS OFFICERPurchase (P): 5,000 @ $4.01EDGAR
2022-04-134Samsara BioCapital, L.P. — 10% owner
AKKARAJU SRINIVAS — 10% owner
Purchase (P): 74,464 @ $4.07 · Purchase (P): 350,000 @ $4.08EDGAR
2022-04-054Young Alethia — Chief Financial OfficerGrant/award (A): 350,000 (derivative) @ $0EDGAR
2022-02-184Lehrer-Graiwer Joshua — PRESIDENT AND CEO, DirectorGrant/award (A): 650,000 (derivative) @ $0EDGAR
2022-02-184Gutry Phil — CHIEF BUSINESS OFFICERGrant/award (A): 115,000 (derivative) @ $0EDGAR
2022-01-254Samsara BioCapital, L.P. — 10% owner
AKKARAJU SRINIVAS — 10% owner
Purchase (P): 100,000 @ $8.99 · Purchase (P): 23,000 @ $8.70EDGAR
2022-01-214Samsara BioCapital, L.P. — 10% owner
AKKARAJU SRINIVAS — 10% owner
Purchase (P): 54,565 @ $9.24 · Purchase (P): 43,105 @ $8.92EDGAR
2021-12-204Samsara BioCapital, L.P. — 10% owner
AKKARAJU SRINIVAS — 10% owner
Purchase (P): 22,329 @ $10.19EDGAR
2021-11-244Samsara BioCapital, L.P. — 10% owner
AKKARAJU SRINIVAS — 10% owner
Purchase (P): 201,685 @ $10.15EDGAR
2021-10-154Samsara BioCapital, L.P. — 10% owner
AKKARAJU SRINIVAS — 10% owner
Purchase (P): 45,400 @ $13.22 · Purchase (P): 3,100 @ $12.50 · Purchase (P): 2,300 @ $12.49EDGAR
2021-10-084Samsara BioCapital, L.P. — 10% owner
AKKARAJU SRINIVAS — 10% owner
Purchase (P): 61,475 @ $13.83 · Purchase (P): 9,021 @ $14.94 · Purchase (P): 75,000 @ $13.12EDGAR
2021-07-014Stultz Katherine V — CHIEF OPERATING OFFICERConversion (C): 8,126 · Grant/award (A): 99,753 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · Grant/award (A): 209,846 (derivative) @ $0 · Grant/award (A): 89,934 (derivative) @ $0 · Conversion (C): 19,763 (derivative) @ $0EDGAR
2021-07-014Shah Smital — DirectorPurchase (P): 5,882 @ $17 · Grant/award (A): 93,585 (derivative) @ $0EDGAR
2021-07-014Lehrer-Graiwer Joshua — PRESIDENT AND CEO, DirectorOption exercise (M): 374,013 @ $0.30 · Conversion (C): 8,126 · Grant/award (A): 374,013 (derivative) @ $0 · Option exercise (M): 374,013 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · Grant/award (A): 795,196 (derivative) @ $0 · +2 moreEDGAR
2021-07-014Jerel Davis — Director, 10% ownerConversion (C): 12,343,727 · Conversion (C): 1,527,719 · Purchase (P): 180,000 @ $17 · Conversion (C): 30,019,945 (derivative) · Conversion (C): 3,715,415 (derivative)EDGAR
2021-07-014Versant Venture Capital VI, L.P. — 10% owner
Versant Ventures VI GP, L.P. — 10% owner
Versant Ventures VI GP-GP, LLC — 10% owner
Versant Vantage II, L.P. — 10% owner
Versant Vantage II GP, L.P. — 10% owner
Versant Vantage II GP-GP, LLC — 10% owner
Conversion (C): 12,343,727 · Conversion (C): 1,527,719 · Purchase (P): 180,000 @ $17 · Conversion (C): 30,019,945 (derivative) · Conversion (C): 3,715,415 (derivative)EDGAR
2021-07-014Gutry Phil — CHIEF BUSINESS OFFICEROption exercise (M): 91,406 @ $0.30 · Option exercise (M): 3,383 @ $6.11 · Conversion (C): 8,126 · Grant/award (A): 91,406 (derivative) @ $0 · Option exercise (M): 91,406 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · +4 moreEDGAR
2021-07-014KARSEN PERRY A — DirectorConversion (C): 8,126 · Grant/award (A): 74,794 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · Grant/award (A): 18,698 (derivative) @ $0 · Conversion (C): 19,763 (derivative) @ $0EDGAR
2021-07-014Samsara BioCapital, L.P. — 10% owner
436, L.P. — 10% owner
AKKARAJU SRINIVAS — 10% owner
Conversion (C): 6,167,763 · Conversion (C): 741,107 · Conversion (C): 22,753 · Purchase (P): 485,000 @ $17 · Purchase (P): 15,000 @ $17 · Conversion (C): 15,000,000 (derivative) @ $0 · +2 moreEDGAR
2021-07-014JIMENEZ JOSEPH — DirectorOption exercise (M): 49,876 @ $0.30 · Conversion (C): 8,126 · Grant/award (A): 49,876 (derivative) @ $0 · Option exercise (M): 49,876 (derivative) @ $0 · Grant/award (A): 19,763 (derivative) @ $5.06 · Grant/award (A): 12,469 (derivative) @ $0 · +1 moreEDGAR
2021-06-284Carlo Rizzuto — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-284Bassan Abraham — DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2021-06-284Jerel Davis — Director, 10% ownerGrant/award (A): 10,000,000 (derivative) @ $1 · Grant/award (A): 3,715,415 (derivative) @ $5.06 · Grant/award (A): 40,000 (derivative) @ $0EDGAR

Recent 8-K events — Graphite Bio, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-10-288-K2.02 — Results of Operations and Financial Condition
?
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-128-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-248-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-128-K8.01 — Other EventsEDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-10-088-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=GRPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs